Source:http://linkedlifedata.com/resource/pubmed/id/12874251
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2003-7-22
|
pubmed:abstractText |
Heme oxygenase-1 (HO-1), a rate-limiting enzyme in heme catabolism, exhibits potent antioxidant and anti-inflammatory properties. We developed HO-1 transgenic (Tg) mice using a rat HO-1 genomic transgene under the control of the endogenous promoter. Transgene expression was demonstrated by RT-PCR in all studied tissues, and a modest HO-1 overexpression was documented by Western, ELISA, and enzyme activity assays. To assess the effect of local vs systemic HO-1 in the acute rejection response, we used Tg mice as organ donors or recipients of MHC-incompatible heart grafts. In the local HO-1 overexpression model, Tg allografts survived 10.5 +/- 0.7 days (n = 10), compared with 6.5 +/- 0.4 days (n = 6) for wild-type donor controls (p = 0.0001). In the systemic HO-1 overexpression model, Tg recipients maintained allografts for 26.8 +/- 3.4 days (n = 10), compared with 6.3 +/- 0.1 days (n = 12) in wild-type controls (p = 0.00009). Inhibition of HO activity by treatment with tin protoporphyrin blunted survival advantage in Tg mice and resulted in acute graft rejection (n = 3). Increased carboxyhemoglobin levels were consistently noted in Tg mice. Comparisons of grafts at day 4 indicated that HO-1 overexpression was inversely associated with vasculitis/inflammatory cell infiltrate in both models. Hearts transplanted into Tg recipients showed decreased CD4(+) lymphocyte infiltration and diminished immune activation, as judged by CD25 expression. Thus, although local and systemic HO-1 overexpression improved allograft outcomes, systemic HO-1 led to a more robust protection and resulted in a significant blunting of host immune activation. This Tg mouse provides a valuable tool to study mechanisms by which HO-1 exerts beneficial effects in organ transplantation.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-1767
|
pubmed:author |
pubmed-author:AraujoJesus AJA,
pubmed-author:BuelowRolandR,
pubmed-author:BusuttilRonald WRW,
pubmed-author:HancockWayne WWW,
pubmed-author:IshikawaKazunobuK,
pubmed-author:IyerSuhasiniS,
pubmed-author:Kupiec-WeglinskiJerzy WJW,
pubmed-author:LeeAnnieA,
pubmed-author:LusisAldons JAJ,
pubmed-author:MengLingzhongL,
pubmed-author:RioD CDC,
pubmed-author:ShihDiana MDM,
pubmed-author:TwardAaron DAD
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
171
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1572-80
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12874251-Animals,
pubmed-meshheading:12874251-Crosses, Genetic,
pubmed-meshheading:12874251-Gene Expression Regulation,
pubmed-meshheading:12874251-Graft Enhancement, Immunologic,
pubmed-meshheading:12874251-Graft Rejection,
pubmed-meshheading:12874251-Graft Survival,
pubmed-meshheading:12874251-Heart Transplantation,
pubmed-meshheading:12874251-Heme Oxygenase (Decyclizing),
pubmed-meshheading:12874251-Heme Oxygenase-1,
pubmed-meshheading:12874251-Membrane Proteins,
pubmed-meshheading:12874251-Mice,
pubmed-meshheading:12874251-Mice, Inbred C57BL,
pubmed-meshheading:12874251-Mice, Transgenic,
pubmed-meshheading:12874251-Rats,
pubmed-meshheading:12874251-Transgenes,
pubmed-meshheading:12874251-Transplantation, Homologous
|
pubmed:year |
2003
|
pubmed:articleTitle |
Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse.
|
pubmed:affiliation |
Division of Cardiology, University of California, Los Angeles, CA 90095, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|